Physician profile
Tripti Pawar
NPI 1013210939
$2,221.71
in general payments reported to CMS, 2019-2025
5 companies · $1,843 in 2025
The $1,843 reported for 2025 was more than what 95% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.03 · 2020: $98.97 · 2021: $36.77 · 2022: $58.44 · 2023: $6.38 · 2024: $163 · 2025: $1,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $915 · Food and Beverage: $749 · Education: $325 · Gift: $23.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $914.76 |
| Food and Beverage | $748.85 |
| Education | $325.00 |
| Gift | $23.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,797.48 | 2021-2025 | Invisalign, Invisalign First - Comprehensive Phase 2 |
| American Orthodontics Corporation | $255.37 | 2020-2025 | Radiance, Empower-Ceramic, LP and Ifit Tubes |
| Zimvie INC. | $138.76 | 2024-2025 | |
| Solventum Corporation | $15.07 | 2024 | Apc II Victory Series Low Profile, Apc II Unitek Gemini |
| World Class Technology Corporation | $15.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tripti Pawar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.